These findings indicate that M100907 suppresses the CaMKII/HDAC4 pathway, which is most likely downstream of the 5-HT2A receptor, resulting in the prevention of cardiac hypertrophy in mice. This evidence concerns the gene HDAC4 and cardiac hypertrophy.